GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tibet Aim Pharm Inc (SZSE:002826) » Definitions » Institutional Ownership

Tibet Aim Pharm (SZSE:002826) Institutional Ownership : 0.64% (As of Mar. 27, 2025)


View and export this data going back to 2016. Start your Free Trial

What is Tibet Aim Pharm Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Tibet Aim Pharm's institutional ownership is 0.64%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Tibet Aim Pharm's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Tibet Aim Pharm's Float Percentage Of Total Shares Outstanding is 0.00%.

Tibet Aim Pharm Institutional Ownership Historical Data

The historical data trend for Tibet Aim Pharm's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tibet Aim Pharm Institutional Ownership Chart

Tibet Aim Pharm Historical Data

The historical data trend for Tibet Aim Pharm can be seen below:

2024-04-30 2024-05-31 2024-06-30 2024-07-31 2024-08-31 2024-09-30 2024-10-31 2024-11-30 2024-12-31 2025-01-31
Institutional Ownership 2.76 2.76 0.64 0.64 0.64 0.64 0.64 0.64 0.64 0.64

Tibet Aim Pharm Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

Tibet Aim Pharm Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tibet Aim Pharm Inc (SZSE:002826) » Definitions » Institutional Ownership
Comparable Companies
SZSE:002817 SZSE:300519 SZSE:000590 SZSE:300391 BJSE:430017 SZSE:300086 BJSE:873167 SZSE:300254 BJSE:836433 SHSE:600381 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD XSWX:SDZ XTAE:TEVA NSE:DIVISLAB HKSE:03692
Traded in Other Exchanges
N/A
Address
No. 6, Linqionggang Road, Lhasa Economic and Technological Development Zone, Tibet Autonomous Region, Lhasa, CHN, 610000
Website
http://www.emyy.cn
Tibet Aim Pharm Inc is the pharmaceutical company based in China. It is mainly engaged in the research and development, production and sales of chemical drugs and proprietary Chinese medicines for common chronic diseases such as diabetes and cardiovascular disease as well as medicines for gynecology and obstetrics. The company's products offering includes miglitol tablets, gualoupi injection, nalmefene hydrochloride injection, carbetocin injection; hongjin xiaojie tablets and aceclofenac enteric-coated tablets. The company also expanded its products in the treatment of antibiotic, antiallergic and digestive system.
Executives
Peng Hui Director
Pang Guo Qiang Directors, executives
Li Qian Jin Securities Affairs Representative
Liu Hang Supervisors

Tibet Aim Pharm Headlines

No Headlines